Eradicating micrometastases with immune checkpoint blockade: Strike while the iron is hot
Author:
Funder
National Cancer Institute
National Institutes of Health
Publisher
Elsevier BV
Subject
Cancer Research,Cell Biology,Oncology
Reference13 articles.
1. Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma;Amaria;Nat. Med.,2018
2. Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial;Bellmunt;Lancet Oncol.,2021
3. Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma;Blank;Nat. Med.,2018
4. Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers;Chalabi;Nat. Med.,2020
5. Adjuvant ipilimumab versus placebo after complete resection of stage III melanoma: long-term follow-up results of the European Organisation for Research and Treatment of Cancer 18071 double-blind phase 3 randomised trial;Eggermont;Eur. J. Cancer,2019
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Neoadjuvant Chemotherapy in Colon Cancer: More Than Just an Optical Illusion;Journal of Clinical Oncology;2024-09-01
2. The efficacy of neoadjuvant immunotherapy combined with chemotherapy in elderly patients with gastric cancer: A subgroup analysis of the NEOSUMMIT‐01 study;AGING MEDICINE;2024-08
3. Immune-checkpoint blockade in surgical management of gastric or gastro-oesophageal junction adenocarcinoma;The Lancet Gastroenterology & Hepatology;2024-08
4. A current comprehensive role of immune-checkpoint inhibitors in resectable non-small cell lung cancer: A narrative review;Journal of Oncology Pharmacy Practice;2024-06-11
5. Bladder Cancer and the Urinary Microbiome—New Insights and Future Directions: A Review;Clinical Genitourinary Cancer;2024-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3